A post-translational regulatory map of chronic antigen-driven human T cell dysfunction

Hiroyuki Kojima1,2, Charlotte R Wayne1,2, Luis F Somarribas Patterson1,3

  • 1These authors contributed equally.

Insights

Chronic antigen exposure causes T cell dysfunction, impairing self-renewal and killing ability. This study reveals key proteomic changes and identifies stress pathways that can be targeted to enhance cancer immunotherapy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • T cells exposed to persistent antigens, as seen in chronic infections or cancer, exhibit diminished self-renewal and cytotoxic functions.
  • While transcriptional, epigenetic, and metabolic factors are known drivers of T cell dysfunction, post-transcriptional regulation remains less understood.

Purpose of the Study:

  • To elucidate the post-transcriptional regulatory mechanisms governing T cell dysfunction during chronic antigen exposure.
  • To characterize the proteomic landscape of human T cells undergoing antigen-driven dysfunction over time.

Main Methods:

  • Time-resolved proteomic analysis of human T cells subjected to persistent T cell receptor stimulation.
  • Investigation of changes in canonical exhaustion-associated proteins, mitochondrial function, redox homeostasis, nucleotide metabolism, and cell-cycle progression.
  • Validation of identified stress response pathways in vivo and assessment of their impact on T cell cytotoxic capacity.

Main Results:

  • Persistent T cell receptor stimulation led to significant proteomic remodeling in T cells.
  • Observed alterations included changes in T cell exhaustion markers, mitochondrial proteins, redox homeostasis regulators, nucleotide metabolism enzymes, and cell-cycle proteins.
  • Activation of specific stress response pathways in dysfunctional T cells was confirmed in vivo and found to influence cytotoxic function.

Conclusions:

  • The study provides a comprehensive proteomic resource detailing post-transcriptional changes in dysfunctional T cells.
  • Targeting identified stress response pathways holds potential for enhancing T cell-mediated cancer immunotherapy.
  • Novel cysteine-directed therapeutics may be developed to reinvigorate T cell function in cancer patients.